Catalyst Wire Dossier Catalyst Wire Dossier

Xcopri

cenobamate · SK Life Science, Inc.
Drug timelines are a Plus or Pro feature.

12 regulatory and trial events tracked for Xcopri, covering 2019-11-21 to 2026-04-03. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy Study of Cenobamate in Pediatric Subjects 2-17 Years of Age With Partial-onset (Focal) Seizures [Phase 3]

See pricing